Vendor review
Shanghai JinBei Chemical Technology reviews
Shanghai JinBei Chemical Technology reviews from 37 independent lab tests (Tirzepatide, Retatrutide and GHK-Cu): grade A, purity and fill accuracy. Is Shanghai JinBei Chemical Technology legit? See what its vials showed.
What the lab tests show
37 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Jun 16, 2026 | GHK-Cu | 99.6 % | 44.5 mg of 50 mg (-11 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.6 % | 98.3 mg of 100 mg (-2 %) | Pass | View |
| Jun 8, 2026 | Tirzepatide | 99.8 % | 21.8 mg of 20 mg (9 %) | Pass | View |
| Jun 8, 2026 | Retatrutide | 99.8 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Jun 8, 2026 | Tirzepatide | 99.8 % | 23.2 mg of 20 mg (16 %) | Pass | View |
| Jun 8, 2026 | Tirzepatide | 99.7 % | 33.6 mg of 30 mg (12 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 34.1 mg of 30 mg (14 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 7.3 mg of 10 mg (-27 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.9 % | 95.1 mg of 100 mg (-5 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 8.8 mg of 10 mg (-12 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.9 % | 15.5 mg of 15 mg (3 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.9 % | 113 mg of 100 mg (13 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.9 % | 53.8 mg of 50 mg (8 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.74 % | 55.8 mg of 60 mg (-7 %) | Pass | View |
| Feb 20, 2026 | Cagrilintide | 99.9 % | 4.86 mg of 5 mg (-3 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 96.96 % | 2.2 mg of 2 mg (10 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 99.5 % | 23.7 mg of 20 mg (19 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.8 % | 20.4 mg of 20 mg (2 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 98.93 % | 41.4 mg of 40 mg (3 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 99.16 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 99.67 % | 18.2 mg of 20 mg (-9 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 99.19 % | 61 mg of 60 mg (2 %) | Pass | View |
| Feb 2, 2026 | Cagrilintide | 98.88 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.6 % | 41.4 mg of 40 mg (3 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 97.63 % | 13.3 mg of 15 mg (-11 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.9 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.8 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99.8 % | 14.8 mg of 10 mg (48 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99.9 % | 29.3 mg of 30 mg (-2 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.9 % | 31.8 mg of 30 mg (6 %) | Pass | View |
| Jan 22, 2026 | Cagrilintide | 85.5 % | 2.9 mg of 5 mg (-42 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.7 % | 26.2 mg of 30 mg (-13 %) | Pass | View |
| Dec 29, 2025 | GHK-Cu | 99.93 % | 113 mg of 100 mg (13 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.89 % | 14.8 mg of 15 mg (-1 %) | Pass | View |
| Dec 29, 2025 | Tesamorelin | 99.95 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Dec 13, 2025 | Retatrutide | 99.8 % | 36.9 mg of 40 mg (-8 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.95 % | 16.1 mg of 15 mg (7 %) | Pass | View |
What Shanghai JinBei Chemical Technology sells
No current listings on record.
About Shanghai JinBei Chemical Technology
Finnrick has tested 37 samples from Shanghai JinBei Chemical Technology across 5 products.